Press Release

The full press release can be downloaded as a pdf.

YMC acquires ChromaCon

Zurich, Switzerland / Kyoto, Japan. April 9, 2019.

YMC Co., Ltd. (“YMC”), a leading supplier of separation resins, services and systems for the pharmaceutical market, has acquired all shares in ChromaCon AG (Zurich, Switzerland) and executed the transfer of 100% shares in the Company on April 1st, 2019.
ChromaCon AG, founded as spin-off from ETH Zurich and a life science tool company, is a leader in continuous chromatography technologies. ChromaCon markets laboratory-scale purification systems employing its process technologies, process simulation and operating software. ChromaCon has pioneered twin-column purification, significantly increasing productivity in large (biopharmaceutical) and small (pharmaceutical) molecule manufacturing, thereby reducing operational cost.
YMC and ChromaCon have been cooperating in Japan and India for the marketing & sale of ChromaCon’s lab-scale systems. In addition, ChromaCon has licensed proprietary technologies to YMC Process Technologies (“YPT”) for GMP production scale equipment. YMC completed its acquisition of YPT from LEWA-Nikkiso America in December 2018. YPT develops and manufactures pilot- and production-scale separation systems for the (bio-)pharmaceutical manufacturing industry.
Michael Bavand, CEO of ChromaCon, commented: “We have been working productively with YPT in development, launch and co-marketing of continuous chromatography pilot/production systems during the past three years achieving a market pole position in industrial implementation of our technology with key customers. We are looking forward to intensifying our interactions being part of the YMC Group of Companies. The acquisition of ChromaCon will benefit our customers ensuring a seamless transfer of our business relationship, technologies and products to YMC.”
Potential questions and answers around the transaction are attached. Further information can be requested from both ChromaCon and YMC.

About ChromaCon AG

ChromaCon is a life science tool company located at Zurich, Switzerland, providing best-in-class chromatography process solutions to the pharmaceutical industry. ChromaCon has developed and patented novel process principles, process control and simulation software, equipment designs and operating software for batch, cyclic and continuous chromatography. These process solutions result in significant CAPEX and OPEX cost savings and enabling scalable chromatographic solutions for large-scale purification applications. The Contichrom® laboratory-scale equipment is co-marketed worldwide by ChromaCon and its partners. ChromaCon has provided global licenses for its process technologies to YPT for implementation into scale-up systems.

ChromaCon Contact

To find out more about ChromaCon please contact us directly.
Dr. Michael Bavand, CEO, info@chromacon.com, www.chromacon.com.

About YMC Co., Ltd.

YMC is a private life science company headquartered in Kyoto, Japan. Founded in 1980, YMC has over 9 affiliates and facilities throughout Asia, Europe and America. The over 500 employees are providing best-in-class lab and process solutions to pharmaceutical industry. YMC focus is in innovation, production and sales of packing materials, packed columns and systems for High Performance Liquid Chromatography (HPLC), Low Pressure Liquid Chromatography (LPLC) and custom purification and custom synthesis. YMC operates a CMO facility and pilot plant incorporating state of the art simulated moving bed (SMB) purification. YMC is also engaged in the production and sales of micro-reactor systems. YMC’s intellectual properties, cultivated from many years of experience, will continue to push the limits to create a prosperous future for purification and discovery of small and large molecule therapies.

YMC Contact

To find out more about YMC please contact us directly or visit our website.
Hideshi Nakabayashi, h-nakabayashi@ymc.co.jp.
www.ymc.co.jp.